11 Ergebnisse

  • BMD Software

    Aussteller
    Portugal
    BMD is an SME targeted to the development of novel biomedical software solutions. Its main specialization areas are medical imaging (PACS), telemedicine, biomedical applications (data mining, knowledge extraction, data integration) and bioinformatics solutions. All of BMD’s developed and marketed technology is 100% Portuguese. The members of the team have +20-years of experience in the field, which allows BMD to provide high-quality and innovative services.
    Merken
  • Vincent HILLENMEYER

    Fachbesucher von VIDAL GROUP / M3
    VP Corporate Development
    Business Development, Direktor
    Potential partnerships, including M&A opportunities
    Merken
  • Tommi Kaasalainen

    Ansprechpartner von Nukute Ltd.
    CEO
    Customers and distributor/reseller partners A new way to screen and diagnose sleep apnea.
    Merken
  • Kauko Oy

    Aussteller
    Finnland
    Merken
  • Kinepict Health Ltd.

    Aussteller
    Ungarn
    Die kinetische Bildgebung kann Blutgefäßstrukturen visualisieren, indem die Bewegung des Bolus mit jodiertem oder CO2-Kontrastmittel erfasst wird; Innovation: DVA-Visualisierung bietet eine erheblich bessere Bildqualität als DSA; Ergebnisse: Signifikante Kontrastmittel- (50%) und Röntgendosisreduktion (bis zu 12%)
    Merken
  • Luis Marques

    Fachbesucher von SWORD Health
    Business Development
    Business Development
    Insurance companies looking to reduce their MSK cost structure. Turn-key solution platform for managing MSK chronic conditions.
    Merken
  • Monidor Oy

    Aussteller
    Finnland
    Merken
  • Nukute Ltd.

    Aussteller
    Finnland
    Sleep Apnea is a common health problem. Nearly a billion people worldwide are estimated to have Sleep Apnea. Despite the increasing demand for faster diagnosis and effective treatment, there is a lack of technological advances and resources in the conventional clinical setting. The prevailing diagnostic test for sleep apnea tends to be inadequate and costly; which limits patient access to testing. As a result, as many as 90% of people with sleep apnea could remain undiagnosed.
    Merken
  • Oy Neurosonic Finland Ltd

    Aussteller
    Finnland
    Merken
  • Nico Rahm

    Fachbesucher von BusinessOulu / OuluHealth
    Market Development Manager
    Business Development
    Merken
  • Juha-Matti Ranta

    Ansprechpartner von Medanets Oy
    CEO
    Geschäftsführer / Vorstand
    New potential customers and partners. Let's change the patient care for the better, together! An open and trustworthy partnership. We truly believe in a health eco-system in which partners come together to solve healthcare challenges. It’s more about creating value together. To us and our partners, nothing is impossible. Together, we are contributing to saving lives.
    Merken